Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
4 raisons identifiées
Auteur de référence en rhumatologie
27 articles scientifiques publiés — un praticien à la pointe de la recherche
Cabinet de groupe — continuité de soins
Plusieurs praticiens dans le même cabinet — un confrère peut prendre le relais en cas d'absence
Disponibilité géographique
2 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
73.1 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CH CHICN COMPIÈGNE
ZAC DE MERCIÈRE - ZONE 3 8 AV HENRI ADNOT BP 50 029, 60321 COMPIEGNE CEDEX
SELARL DU DOCTEUR CATALINA ILIESCU
CABINET MEDICAL 19-21RUE DE L'OISE RUE DE L OISE, 60200 COMPIEGNE
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Genome medicine · 2023
Abstract Background Systemic lupus erythematosus (SLE) is known to be clinically heterogeneous. Previous efforts to characterize subsets of SLE patients based on gene expression analysis have not been reproduced because of small sample sizes or technical problems. The aim of this study was to develop a robust patient stratification system using gene expression profiling to characterize individual lupus patients. Methods We employed gene set variation analysis (GSVA) of informative gene modules to identify molecular endotypes of SLE patients, machine learning (ML) to classify individual patients into molecular subsets, and logistic regression to develop a composite metric estimating the scope of immunologic perturbations. SHapley Additive ExPlanations (SHAP) revealed the impact of specific features on patient sub-setting. Results Using five datasets comprising 2183 patients, eight SLE endotypes were identified. Expanded analysis of 3166 samples in 17 datasets revealed that each endotype had unique gene enrichment patterns, but not all endotypes were observed in all datasets. ML algorithms trained on 2183 patients and tested on 983 patients not used to develop the model demonstrated effective classification into one of eight endotypes. SHAP indicated a unique array of features influential in sorting individual samples into each of the endotypes. A composite molecular score was calculated for each patient and significantly correlated with standard laboratory measures. Significant differences in clinical characteristics were associated with different endotypes, with those with the least perturbed transcriptional profile manifesting lower disease severity. The more abnormal endotypes were significantly more likely to experience a severe flare over the subsequent 52 weeks while on standard-of-care medication and specific endotypes were more likely to be clinical responders to the investigational product tested in one clinical trial analyzed (tabalumab). Conclusions Transcriptomic profiling and ML reproducibly separated lupus patients into molecular endotypes with significant differences in clinical features, outcomes, and responsiveness to therapy. Our classification approach using a composite scoring system based on underlying molecular abnormalities has both staging and prognostic relevance.
Cell death & disease · 2023
AbstractPediatric Acute Myeloid Leukemia (AML) is a rare and heterogeneous disease characterized by a high prevalence of gene fusions as driver mutations. Despite the improvement of survival in the last years, about 50% of patients still experience a relapse. It is not possible to improve prognosis only with further intensification of chemotherapy, as come with a severe cost to the health of patients, often resulting in treatment-related death or long-term sequels. To design more effective and less toxic therapies we need a better understanding of pediatric AML biology. The NUP98-KDM5A chimeric protein is exclusively found in a particular subgroup of young pediatric AML patients with complex karyotypes and poor prognosis. In this study, we investigated the impact of NUP98-KDM5A expression on cellular processes in human Pluripotent Stem Cell models and a patient-derived cell line. We found that NUP98-KDM5A generates genomic instability through two complementary mechanisms that involve accumulation of DNA damage and direct interference of RAE1 activity during mitosis. Overall, our data support that NUP98-KDM5A promotes genomic instability and likely contributes to malignant transformation.
Journal of pediatric surgery · 2023
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Journal of clinical medicine · 2025 · Journal Article
Popa A, Stăncioiu AA, Motofelea AC, Câlniceanu H, et al.
Journal of clinical medicine · 2025 · Journal Article
Coseru AI, Khemissa F, Floria DE, Simiras C, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference · 2025 · Journal Article
G A, C G, C J M, B L, et al.
BMC medical education · 2025 · Journal Article
Soledad AR, Catalina ZS, Scarlett VC, Claudia BP, et al.
Journal of personalized medicine · 2024 · Journal Article
Sánchez-López AM, Catalina P, Franco F, Panadero-Fajardo S, et al.
Gastroenterologia y hepatologia · 2023 · Multicenter Study
Berenguer M, Vergara M, Almohalla C, Hernandez A, et al.
Annals of the rheumatic diseases · 2023 · Letter
C SK, Ahmed S, Shenoy V, Menon AR, et al.
Case reports in dentistry · 2026 · Journal Article
Araceli TUC, Juan LEC, Alberto MPL, Vanessa SVB, et al.
Journal of viral hepatitis · 2025 · Journal Article
Conthe A, Fueyo PR, Aguilera F, Iniesta C, et al.
Cureus · 2025 · Case Reports
C P, Ann Jose J, Verma G, Priya V L, et al.
Cureus · 2024 · Case Reports
Ramanan A, Balasubramanian V, C R, Sami P
Health psychology report · 2025 · Journal Article
Díaz-Rodríguez C, Martínez-López F, Catalina ÁD
European journal of pediatrics · 2024 · Journal Article
Yıldız Ç, Küçükali B, C SSB, Şenol PE, et al.
Pediatric surgery international · 2024 · Journal Article
Margarita G, Catalina C, Ana B, Bélgica C, et al.
Advances in protein chemistry and structural biology · 2026 · Journal Article
Loganathan T, Madhulekha S, Zayed H, C GPD
Genome medicine · 2023 · Published Erratum
Hubbard EL, Bachali P, Kingsmore KM, He Y, et al.
Genome medicine · 2023 · Journal Article
Hubbard EL, Bachali P, Kingsmore KM, He Y, et al.
Journal of viral hepatitis · 2025 · Journal Article
Conthe A, Fueyo PR, Aguilera F, Iniesta C, et al.
World journal of plastic surgery · 2025 · Journal Article
Juan Esteban OG, María Gabriela LA, María Camila AG, Edgar Felipe MS, et al.
Cureus · 2024 · Case Reports
Ramanan A, Balasubramanian V, C R, Sami P
European journal of pediatrics · 2024 · Journal Article
Yıldız Ç, Küçükali B, C SSB, Şenol PE, et al.
Journal of clinical and experimental hepatology · 2025 · Journal Article
Conthe A, Ibañez-Samaniego L, Calleja E, Saralegui P, et al.
BMC psychiatry · 2026 · Journal Article
Fuster-Casanovas A, Moretó S, Catalina QM, Vidal-Alaball J, et al.
Cureus · 2025 · Case Reports
Lakshme I, C A, Senthil N, Pandurangan V
Cureus · 2026 · Case Reports
R S, Nanda M S, Adalarasan S, Subramanian Y, et al.
JBJS case connector · 2024 · Case Reports
C A, Raju A, Meleppuram JJ, Nair AV, et al.
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2023 · Journal Article
Conthe A, Ibáñez-Samaniego L, Muñoz MF, Ortega V, et al.
Journal of pediatric surgery · 2023 · Journal Article
Juan HL, Nicolas AM, Daniela CL, Lineth OM, et al.
Cell death & disease · 2023 · Journal Article
Domingo-Reinés J, Montes R, Garcia-Moreno A, Gallardo A, et al.
Lupus · 2023 · Journal Article
Patil A, Shobha V, Shenoy P, S C, et al.